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Pacutaneous transluminal angioplasty may be an elective
revascularization strategy in patients with medically refrac-
tory unstable angina who are at high risk for mortality with
coronary artery bypass graft surgery (1-3). One high risk
subset is patients with previous coronary artery bypass graft
surgery . Coronary angioplasty of saphenous vein grafts can
frequently palliate symptoms (8-14) . Adjunctive use of
thrombolytic agents may make this approach safer (19.20). A
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recent review suggests that although coronary augiapisty is
an option for discrete lesions in recent sapYnous vein
grafts, old Occluded vein graft lesions, lesions in which graft
closure is likely to result in shock or lesions in grafts
24 years old are prone to acute complications ; and a poor
clinical outcome (g) .
This report summarizes angigraphic and long-term clio-
ical outcome in 75 consecutive patients who underwent
coronary angoplasty of ore or more saphenoua vein graft
lesions fir medically refractory ischemlc syndromes. This
series includes patients with both anatomic and physiologic
extremes who arm at Increased risk for repeat bypass sur-
pry . Shunt-term clinical coronary angioplasty results in
these patients were contrasted with proected and observed
outcomes from the Veterans Affairs Surgical Registry of the
coronary artery bypass graft alternative .
Long-term
clinical
follow-up was provided. This report supports the concept
that coronary angioplasty of saphenous vein graft lesions is
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an alternative to reoperation in patients with medically
refractory unstable angina and previous coronary artery
bypass graft tmgery.
Methods
Patient group . Between December 1986 and March 1993 .
'S patients with unstable angina and at least one previous
,oronary artery bypass graft operation underwent saphe-
ous vein graft bailooa angioplasty . All patients had severe
tsehemic syndromes (Canadian angina classes III and IV
despite medical therapy. Thirty-six patients had reversible
electrocardiographic changes of ischemia recorded at rest .
Mglepiassy protects. Coronary angioplasty was per-
formed by standard technique (3)
. All patients were treated
with aspirin (325 mg every day) and intravenous hepatic or
nitroglycerin, or both. Seventy patients (93%) consented to
salvage coronary angioplasty, which specified that no surgi-
cal standby was available because of the surgeons percep-
tiao of "prohibitive" risk (3). insraaortic balloon augasenta-
lion was instituted because of hemodytamic instability in
nine patients
. Anatomic assessment of lesion severity was
determined by visual inspection in two or more angiographic
views . Intravenous heparin (10,000-U bolus with periodic
additional boluses) was given to a8 patients
. Adjunctive
plsemacotherapy Included 1) in racoronary nitroglycerin
(>208 pg) in every patient; 2) inuasapheasras vein graft
heparin (5,008 to 20,008 U) in 72 of 75 patients : 3) inea-
sapbenous vein graft orokinnse (250,000 1a I million U) in
16 of 75 patients; and 4) law dose wat8rin (2 to 5 mg)
throughout the hospital stay in 74 of 75 patients .
Ddbd§onw. Aagiarapk k sure-ear was defined as a resid-
td l men narrowing 550% . Compiicatioas were defined as
major if death, myocardial in%rcelon or emergent coronary
artery bypass grafting occurred during index hospitalization .
Cgnied aucren was achieved if stabilization of patient's
c9la'tcalsta ustccurred
. with eventual hospital discharge and
no major complications during the index hospitalization
.
Late cardsc evenrr
were defined as death, myocardial
mihretlon or repeat revascularizstion (coronary artery by-
pass graft sugary or coronary angioplasty) .
Fo6owrgi . All patients were followed up by return clinic
visits, telephone concoct or chart review for clinical symp-
toms, need for repeat revascularization or death. Because
patients were all eligible veterans from Denver's catchment
area, atheteriation. angioplasty and surgical records c(ar
hospital were screened to Identify subsequent procedures in
those patients
Surglral rkk went . Coronary artery bypass graft
surgery survived database been collected by the Department
d Veterans Af<ans Cardiac Risk Assessment Program since
April 1987 in a program to assess preoperative surgical risk
(7). These data have resulted in a logistic
regression
predic
tine model based on 11 risk variables (previous heart sur-
gery, cardiomegdy, age, serum creatinine, presence of pa
dphrtrl vascular disease, presence of chronic obstructive
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pulmonary disease, recent
myocardial
infarction, New York
Heart Association functional class, current diuretic use,
intravenous nitroglycerin ttae, preoperative baboon pump
use) that estimate expected surgical mortality . These vari-
ables have been used to predict the expected surgical risk for
the patients with saphenoss vein graft coronary angioplasty
in this report had they undergone coronary artery bypass
graft surgery. This value can be compared with that for
observed angioplasty mortality .
Coronary artery bypass graft surgery central group
. Pa-
tients with unstable angina who underwent bypass surgery
were extracted from the Veterans Affairs Cardiac Risk
Assessment Program Registry on the basis of the presence of
at least one of the following six high surgical risk factors.
previous corosmy artery bypass graft surgery, age >70
years. myocardial infarction within 30 days, left ventricular
ejection fraction <035, intravenous nitroglycerin required,
istraaortic balloon pump required . A total of 2,370 patients
were found who underwent coronary artery bypass surgery
between April 1. 1987 and December 31, 1988. Survival data
for these patients were obtained from a second dam file
(Beneficiary Idemificalion Records Locator Subsystem) by
matching social security numbers . Experience suggests that
most deaths would appear in this data set but that some
deaths due to coronary artery bypass surgery would be
missed .
Statistical considerations. Observed angioplasty short-
term mortality was compared with predicted coronary artery
bypass surgery mortality, and obi-square analysis was used
to test for differences at the 5% level of
significance.
Follow-up 5-year survival was evaluated by the Kapltm-
Meier product limit estimates for years I to 5 after index
treatment
. This was done for the 75 patients with sapheoous
veinVA coronary angioplasty and for the coronary artery
bypass graft surgery control getup extracted from the Vet-
erans Affairs Cardiac Risk Assessment Program Registry
.
Maadmul likelihood estimates of yearly survival and stan-
dard errors were obtained for censured data to compare
survival in the saphenoua vein graft coronary angioplnsty,
and coronary artery bypass graft surgery control groups.
Differences in survival were tested by a Student r test using
5% statistical significance.
Results
Clinical characteristics. Patient age and graft age mean
values and dstributions are presented in Table 1
. The graft
age averaged over the 75 patients differed little from the
mean age averaged over the 89 lesions (8 .2 vs. 8 .1 years) .
Aeglegrephk reads. Angiographic success for 89 dilated
lesions is summarized in Table 2. Angiographic evidence
suggested saphenous vein graft thrombus In 47 patients
(63%) and consisted of either intralumisal defects with
surrounding dye, jagged edges
with overhanging margins or
occlusions with dye penetration.
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Table S Survival Rate Esdmales After Index Procedure
eavival gate IS)
'p < 0.05
.
b - dmlto seu-yeas of slow-up. CADG = ewot,
grey bypen 1118 sarany :
PICA = peaaatooews trnNuuu,,1 caMK5
Ussrhaty;
IV - 9076 .
curve S(b) = exp(-b x t) where t = years after surgery. This
corresponds to a yearly survival rate (95% confidence inter-
val) or
SIPPA) = exp( - caw) = 94% (91% to 97%1:
S(CABG) = exp( -0A32) =97% (962 to 97%) .
Discussion
In
this highly selected group of patients with coronary
artery bypass gmf surgery and medically, refractory unsta-
ble angina, angioplasty and adjunctive intracosonary phar
n acothempy of odd saphenous vein grafts was a reasonable
alternative to reoperatias. Patients with coronary artery
bypass
gait
surgery who present with unstable ischemic
syndromes frequently arc older, have had a previous or
recent myocardial infarction and . often . significant conor-
bidhy that places these patients al high risk for reoperation.
In the Veterans Alb ins system, where results of a8 coronary
salary bypass operations performed in 45 centers me mom
toned, seuperatiar is associated with -9% mortality (7). This
operative mortality is higher Chum in ants-Veterans Affairs
facilities but reflects the [nee risk for the veteran population .
In our study, the ergirceed 30-day corimry artery bypass
mortality rate was predicted at 19% for these 75 patients had
they unilesli a reeperalion in our hospital
. Although our
MW 3042Y
metality rate for angioplasty was 3% and
compares quite favorably to that predicted for repeat surgery
(18%), the long-term mortality rate for angioplasty was
rig cool at 27% for a 5-mouth to 3-year follow-up period .
However, our study group in general had a relatively
guarded long-term prognosis gives the fact that 31% had a
left ejectim fractiaa 50.35, and 67% had maim comorbidity
(Table 1)
.
In 0 effort to provide a more comparable control than
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projections
. we surveyed the Veterans Affairs Surgical Re ,
istry for patients meeting our criteria of medically refractory
rest angina and high surgical risk
. The high surgical risk
group includes either age >70 years or left ventricular
ejection fraction <0.35 or intravenous nitroglycerin therapy
at time of surgery or inttaaoetic balloon pump at time of
surgery or recent (30 days) myocardial infntction or p=-
coronary bypass graft surgery . This defines the 2,370
veter-
ans
who wee followed up by means of the Beneficiary
Identification Records Locator System and from which we
derived the observed coronary artery bypass graft surgery
deaths shown in Table 0. Because every analysis of Veterans
Affairs Surgical Registry data has shown that post.corotmry
bypass is the highest of these six high risk factors, the
angoplasty group is unequivocally at higher risk than the
bypass surgery group (all patients in the angoplasty group
had bypass surgery)
. Our date suggest that the short-term
survival rate was better after angioplasty, but over a longer
time there was no
difference
Reservations Concerning tog eptasq hr patients after car
onary artery bypass graft surgery
. Angioplasty of old vein
grafts can be complicated by thrombosis
. embolization and
dissection and has been associated with higher rates of
abrupt occlusion and late resteaosis (8-17)
.
Previous reports
have recommended alternative treatment strategies in such
patients (8,17) . The patients studied in this report were also
at risk for abrupt occlusion and complications because all
patients had refractory, unstable angina (21-24) . Restenosis
rates were also higher in this subgroup. Furthermore, a
recent review of the published world data recommends
outran I) with regard to angioplasty of totally occluded
veins ; 2) in angioplasty of vein graft lesions that are likely to
lead to shock with sectusioo; and 3) with grafts z4 years old
ifrepeat bypass surgery is a viable option (8) . We agree with
that position. but our data support extending the application
of angioplasty in selected patients with these characteristics,
especially in patients who are at increased risk for reepera-
tion .
Role d asnod(ve Yraroroaary pbwmamlhaapy. All
patients in this study received adjunctive intraconomay
therapy consisting of heparin, urokinase and nitroglycerin .
To time there are no dam that indicate that intracoronary
heparin prevents score
occlusions
or restenosis in vein
grafts. We routinely and safely administered intracoronary
heparin in all patients aficr angioplasty an theoretic grounds,
but we have no objective data to support its use . Intracoro-
nary wokinase has been effective in recannalization of
occluded or diffusely diseased vein grafts (19,20). Residual
thrombus after angioplasty may also predispose patients to
suhacutc occlusion and reateaosis (34). We routinely admin-
istered intracoronary urokinaae for vein lesions that ap-
peared irregular or hazy or contained obvious filling defects.
Our reported angiographic and clinical success rates in these
high risk patients for short-term complications may reflect in
part the liberal use of adjunctive intracoronary pharmaco-
therapy .
Well
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